Online citations, reference lists, and bibliographies.
← Back to Search

Therapeutic Nanoparticles And Their Targeted Delivery Applications

Abuzer Alp Yetisgin, Sibel Çetinel, Merve Zuvin, Ali Koşar, O. Kutlu
Published 2020 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanotechnology offers many advantages in various fields of science. In this regard, nanoparticles are the essential building blocks of nanotechnology. Recent advances in nanotechnology have proven that nanoparticles acquire a great potential in medical applications. Formation of stable interactions with ligands, variability in size and shape, high carrier capacity, and convenience of binding of both hydrophilic and hydrophobic substances make nanoparticles favorable platforms for the target-specific and controlled delivery of micro- and macromolecules in disease therapy. Nanoparticles combined with the therapeutic agents overcome problems associated with conventional therapy; however, some issues like side effects and toxicity are still debated and should be well concerned before their utilization in biological systems. It is therefore important to understand the specific properties of therapeutic nanoparticles and their delivery strategies. Here, we provide an overview on the unique features of nanoparticles in the biological systems. We emphasize on the type of clinically used nanoparticles and their specificity for therapeutic applications, as well as on their current delivery strategies for specific diseases such as cancer, infectious, autoimmune, cardiovascular, neurodegenerative, ocular, and pulmonary diseases. Understanding of the characteristics of nanoparticles and their interactions with the biological environment will enable us to establish novel strategies for the treatment, prevention, and diagnosis in many diseases, particularly untreatable ones.
This paper references
10.1007/BF01977618
Drug transport across the blood-brain barrier
J. M. Bree (2005)
10.1001/jamaoto.2013.214
Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma.
S. Cohen (2013)
10.1016/j.nano.2008.11.002
Protracted elimination of gold nanoparticles from mouse liver.
E. Sadauskas (2009)
10.1016/j.jconrel.2013.09.013
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.
M. J. Ernsting (2013)
10.1002/art.40504
Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis
J. Falconer (2018)
10.1038/s41416-019-0391-z
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients
Y. Fujiwara (2019)
10.2147/IJN.S146315
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Fakhar ud Din (2017)
10.1351/pac200779101801
Definitions of terms relating to the structure and processing of sols, gels, networks, and inorganic-organic hybrid materials (IUPAC Recommendations 2007)
J. Alemán (2007)
10.1155/2007/76087
Clinical Potential of Quantum Dots
A. M. Iga (2007)
10.2147/IJN.S46900
Nanopharmaceuticals (part 1): products on the market
V. Weissig (2014)
10.1007/s00066-009-1903-1
Strong synergy of heat and modulated electromagnetic field in tumor cell killing
G. Andocs (2009)
10.1002/adma.201305256
Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer.
T. Liu (2014)
10.1016/j.biomaterials.2009.10.011
Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery.
S. Zhang (2010)
10.1016/j.carbpol.2016.11.021
Effective attenuation of vascular restenosis following local delivery of chitosan decorated sirolimus liposomes.
A. Haeri (2017)
10.1016/J.BMC.2007.11.052
Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis.
Sampath C Abeylath (2008)
10.1016/j.addr.2015.10.004
Current advances in self-assembled nanogel delivery systems for immunotherapy.
Y. Tahara (2015)
Neuroprotective e ff ects of novel phosphatidylglycerol - based phospholipids in the 6 - hydroxydopamine model of Parkinson ’ s disease
C. F. Xia (2008)
10.1080/19420862.2016.1204502
In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate
Liuxi Chen (2016)
10.1038/nphys1679
A quantum spin transducer based on nanoelectromechanical resonator arrays
P. Rabl (2010)
10.1088/0957-4484/24/16/165101
In vivo monitoring of distributional transport kinetics and extravasation of quantum dots in living rat liver.
Cheng-Kuan Su (2013)
10.1056/NEJM199903113401004
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
T. Walsh (1999)
10.1016/S0925-9635(97)00312-9
Nano-diamond films produced from CVD of camphor
K. Chakrabarti (1998)
10.1049/ME:19930077
Products to market
L. J. Burbidgh (1993)
10.1016/j.biomaterials.2016.07.002
Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo.
Liangliang Dai (2016)
10.1016/j.ijpharm.2011.10.039
Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation.
A. Azeem (2012)
10.1016/j.ijpharm.2015.03.001
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization.
S. Laserra (2015)
10.1186/s12951-018-0349-y
Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems
N. Liptrott (2018)
10.1039/C3RA47370H
Polymeric micelles as drug delivery vehicles
Z. Ahmad (2014)
10.1002/smll.201703838
Nanodiamonds for In Vivo Applications.
KiranJ. van der Laan (2018)
10.3390/jcm5090082
Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery
J. Y. Yhee (2016)
10.18433/J30C7D
Nanotherapeutics to overcome conventional cancer chemotherapy limitations.
M. Chidambaram (2011)
10.1021/bc5000109
Statistical modeling of the drug load distribution on trastuzumab emtansine (Kadcyla), a lysine-linked antibody drug conjugate.
M. T. Kim (2014)
10.1016/j.jconrel.2011.08.017
Transport of drugs across the blood-brain barrier by nanoparticles.
Stefanie Wohlfart (2012)
A Clinical Study to Measure the Effect of OP-101 after Being Administered Subcutaneous in Healthy Volunteers
10.1039/C5TB02704G
Azo-functionalized Fe3O4 nanoparticles: a near-infrared light triggered drug delivery system for combined therapy of cancer with low toxicity.
Ling Chen (2016)
10.5155/EURJCHEM.2.2.125-129.394
Novel approach for preparing nontoxic stealth microspheres for drug delivery
P. Angra (2011)
10.3390/molecules22091401
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Livia Palmerston Mendes (2017)
10.1073/pnas.0801763105
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
10.3390/ma12101639
Applications of Nanodiamonds in the Detection and Therapy of Infectious Diseases
Eva Torres Sangiao (2019)
10.4103/0973-0168.184606
Magnetic hyperthermia therapy: An emerging modality of cancer treatment in combination with radiotherapy
Neena G. Shetake (2016)
10.1016/j.nano.2016.07.017
Combination therapy of paclitaxel and cyclopamine polymer-drug conjugates to treat advanced prostate cancer.
Ruinan Yang (2017)
10.1039/C8NJ01986J
Cytotoxicity studies of selected cadmium-based quantum dots on 2D vs. 3D cell cultures
I. Grabowska-Jadach (2018)
10.1158/0008-5472.CAN-12-1683
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.
A. Manzoor (2012)
10.1002/btm2.10143
Nanoparticles in the clinic: An update
Aaron C. Anselmo (2019)
10.1007/s40262-019-00809-6
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup
P. Chelle (2019)
10.1211/jpp.58.5.0005
Stavudine‐loaded mannosylated liposomes: in‐vitro anti‐HIV‐I activity, tissue distribution and pharmacokinetics
M. Garg (2006)
10.1016/j.jns.2009.09.032
Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model
R. Huang (2010)
10.3389/fphar.2015.00286
Advances and Challenges of Liposome Assisted Drug Delivery
Lisa Sercombe (2015)
10.1200/JCO.2012.46.2309
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
S. O'brien (2013)
10.1007/s11596-008-0303-6
Antiviral activity of nano carbon fullerene lipidosome against influenza virus in vitro
Hong Ji 季 虹 (2008)
10.1016/j.biomaterials.2008.05.005
Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60).
Z. Marković (2008)
10.2174/1389203718666161122113041
Engineering Virus-like Particles for Antigen and Drug Delivery.
B. D. Hill (2018)
10.1093/BRAIN/AWL280
Therapeutic approaches to Alzheimer's disease.
Hans-Wolfgang Klafki (2006)
10.1016/j.ijpharm.2017.01.067
Protein-based nanoparticles: From preparation to encapsulation of active molecules.
Mohamad Tarhini (2017)
10.1002/ADMA.200801393
Size-Dependent Endocytosis of Nanoparticles.
Sulin Zhang (2009)
10.1177/0885328216659032
Nanobiomaterials’ applications in neurodegenerative diseases
Daniela Silva Adaya (2017)
10.1002/jps.21372
Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors.
N. Shaik (2008)
10.1016/j.tim.2008.11.004
Staphylococcus aureus as an intracellular pathogen: the role of small colony variants.
P. Sendi (2009)
10.1016/j.jsps.2017.10.012
Applications of nanoparticle systems in drug delivery technology
S. A. Rizvi (2018)
Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis
C Bell (2018)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
Stimuli-responsive nanocarriers for drug
S. Mura (2013)
10.3892/OR.12.1.3
Low toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenografts.
T. Boulikas (2004)
10.1016/j.csbj.2015.11.001
Self-assembling protein nanoparticles in the design of vaccines
Jacinto López-Sagaseta (2016)
10.1161/CIRCULATIONAHA.117.029617
Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.
I. Neeland (2018)
10.2217/nnm.09.67
Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.
M. Bondì (2010)
10.7150/thno.21945
Exosome Theranostics: Biology and Translational Medicine
Chuanjiang He (2018)
10.1039/c4cc04936e
Functionalised nanoparticles complexed with antibiotic efficiently kill MRSA and other bacteria.
L. Wang (2014)
10.2147/OTT.S105587
Onivyde for the therapy of multiple solid tumors
H. Zhang (2016)
10.1016/j.biomaterials.2016.03.003
CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation.
Y. Lu (2016)
10.2147/IJN.S68861
Liposomes as nanomedical devices
G. Bozzuto (2015)
Development of Glatopa ( R ) ( Glatiramer Acetate ) : The First FDA - Approved Generic Disease - Modifying Therapy for Relapsing Forms of Multiple Sclerosis
C. Bell (2018)
10.2147/IJN.S3061
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
E. Miele (2009)
10.1002/med.21509
Gold nanoparticles in ophthalmology
F. Masse (2019)
10.1017/S0885715617000896
Crystal structure of paliperidone palmitate (INVEGA SUSTENNA®), C39H57FN4O4
J. Kaduk (2017)
10.1016/j.msec.2018.12.073
Production, surface modification and biomedical applications of nanodiamonds: A sparkling tool for theranostics.
Hussain Tinwala (2019)
10.1016/j.ijpharm.2012.07.006
PEGylated-PLGA microparticles containing VEGF for long term drug delivery.
T. Simón-Yarza (2013)
10.1016/j.carbpol.2014.12.084
Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Y. Luo (2015)
10.1016/j.chemphyslip.2014.03.006
Drug targeting using solid lipid nanoparticles.
E. Rostami (2014)
10.1016/j.jconrel.2016.02.001
Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles.
Kevin Pham (2016)
10.1177/2211068212456198
Nanodiamonds as Platforms for Biology and Medicine
H. Man (2013)
10.1039/c9nr05478b
Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancer.
V. S. Madamsetty (2019)
10.1128/JCM.01889-13
Evaluation of the Nanosphere Verigene Gram-Positive Blood Culture Assay with the VersaTREK Blood Culture System and Assessment of Possible Impact on Selected Patients
S. Beal (2013)
10.1016/J.FREERADBIOMED.2007.05.005
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism.
P. Mróz (2007)
10.1117/1.JBO.19.5.051203
Aptamer-conjugated gold nanorod for photothermal ablation of epidermal growth factor receptor-overexpressed epithelial cancer
J. Choi (2014)
10.1007/s10856-015-5496-1
Macrophage response to chitosan/poly-(γ-glutamic acid) nanoparticles carrying an anti-inflammatory drug
R. Gonçalves (2015)
10.1517/14656566.7.8.1041
Albumin-bound paclitaxel: a next-generation taxane
W. Gradishar (2006)
10.1016/j.jconrel.2010.08.027
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
10.1172/JCI33464
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
A. Basso (2008)
10.1016/j.bioactmat.2018.05.003
Doxorubicin-conjugated pH-responsive gold nanorods for combined photothermal therapy and chemotherapy of cancer
J. Chen (2018)
10.1016/J.AJPS.2014.08.005
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
V. Junyaprasert (2015)
10.7150/thno.3463
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
M. Yu (2012)
10.1016/j.jconrel.2016.01.008
Current applications of nanoparticles in infectious diseases.
H. Zazo (2016)
10.1016/j.brainres.2008.01.039
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
B. Wilson (2008)
10.1016/j.jconrel.2018.03.014
Silica based hybrid materials for drug delivery and bioimaging
Elnaz Bagheri (2018)
10.1007/s11010-019-03545-4
Exosomes: cell-created drug delivery systems
Anastasia Familtseva (2019)
10.2174/1574889810666150702124059
Exosome-based strategies for Diagnosis and Therapy.
L. Urbanelli (2015)
10.2217/nnm-2018-0120
Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.
Fatemeh Farjadian (2019)
10.1016/j.jaac.2013.12.025
Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry.
Natalie Weder (2014)
10.1007/978-3-319-41129-3_2
Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications
Saurabh Bhatia (2016)
10.1021/BC700184B
A macrophage-nanozyme delivery system for Parkinson's disease.
E. Batrakova (2007)
10.1002/ADFM.201302988
Biocompatible, Uniform, and Redispersible Mesoporous Silica Nanoparticles for Cancer‐Targeted Drug Delivery In Vivo
Q. Zhang (2014)
10.1128/AAC.03728-14
Properties of AdeABC and AdeIJK Efflux Systems of Acinetobacter baumannii Compared with Those of the AcrAB-TolC System of Escherichia coli
E. Sugawara (2014)
10.1002/jnr.21805
Polyhydroxylated fullerene derivative C60(OH)24 prevents mitochondrial dysfunction and oxidative damage in an MPP+‐induced cellular model of Parkinson's disease
X. Cai (2008)
10.1016/j.jconrel.2015.01.009
Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats.
Q. Pan (2015)
10.7150/thno.23459
Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications
Wei Wu (2018)
10.1021/ACSBIOMATERIALS.7B00824
Quantum Dots Elicit Hepatotoxicity through Lysosome-Dependent Autophagy Activation and Reactive Oxygen Species Production
J. Fan (2018)
10.3390/ijms19030768
Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
H. Lim (2018)
10.1155/2014/180549
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Warangkana Lohcharoenkal (2014)
10.2147/IJN.S121956
The antimicrobial activity of nanoparticles: present situation and prospects for the future
L. Wang (2017)
10.1016/j.nano.2014.12.014
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.
Howard E. Gendelman (2015)
10.1038/nrc1566
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
10.2147/IJN.S92307
Antimicrobial activity and cytocompatibility of silver nanoparticles coated catheters via a biomimetic surface functionalization strategy
K. Wu (2015)
10.1021/ja2084338
Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.
Carl D. Walkey (2012)
10.1016/j.ejpb.2014.02.005
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data.
S. Doktorovová (2014)
10.2217/THY.11.30
Certolizumab pegol for the treatment of rheumatoid arthritis
I. Modesto (2011)
10.1016/j.nano.2019.02.020
Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer.
V. S. Madamsetty (2019)
10.1016/J.CHEMBIOL.2005.08.014
Cationic fullerenes are effective and selective antimicrobial photosensitizers.
G. Tegos (2005)
10.3390/biomedicines7030049
Physicochemical and Biological Examination of Two Glatiramer Acetate Products
A. Komlosh (2019)
10.1016/j.jconrel.2014.05.051
Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
Z. Chen (2014)
10.1111/j.1460-9568.2007.06018.x
Neuroprotective effects of novel phosphatidylglycerol‐based phospholipids in the 6‐hydroxydopamine model of Parkinson's disease
S. Crotty (2008)
10.1002/jps.24322
A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders.
Zamanzima Mazibuko (2015)
10.1016/j.jconrel.2010.03.016
Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting.
Shyh-Dar Li (2010)
10.1016/j.jconrel.2013.01.032
Biomedical applications of bisphosphonates.
E. Giger (2013)
10.1016/j.ejpb.2008.11.010
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
H. Maeda (2009)
10.1016/j.jconrel.2015.06.024
Enhancing cancer targeting and anticancer activity by a stimulus-sensitive multifunctional polymer-drug conjugate.
Y. Tu (2015)
Recent Drug Delivery Systems for Treatment of Glaucoma
Noha S El-Salamounia (2016)
10.1155/2012/581363
Lipoplatin Formulation Review Article
G. Stathopoulos (2012)
10.1039/c5cc08391e
Near infrared light-responsive and injectable supramolecular hydrogels for on-demand drug delivery.
X. Wang (2016)
10.1002/wnan.1401
Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
Y. H. Lim (2016)
10.1016/j.addr.2010.04.009
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.
J. Fang (2011)
10.2217/nnm-2016-0379
Drug delivery to the eye: what benefits do nanocarriers offer?
R. Joseph (2017)
10.1021/MA00064A011
Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles
K. Akiyoshi (1993)
10.1039/c5bm00052a
Protein nanoparticles for therapeutic protein delivery.
L. Herrera Estrada (2015)
10.1016/j.ejpb.2008.08.003
In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
K. Letchford (2009)
10.1039/C4TB00404C
Enhanced loading and controlled release of rhBMP-2 in thin mineralized collagen coatings with the aid of chitosan nanospheres and its biological evaluations.
Ziqiang Kong (2014)
10.2174/0929867322666150209152259
Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
C. Puglia (2015)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing
O A Cornely
Therapeutic applications of Nanorobots-Respirocytes and Microbivores
P S Shabnashmi (2016)
10.1088/0957-4484/26/14/145102
Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.
Y. Liu (2015)
10.1021/JA056609N
Shape and aggregation control of nanoparticles: not shaken, not stirred.
D. Li (2006)
10.1038/nmat3776
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
10.1016/J.NANTOD.2010.03.003
Targeted Nanodelivery of Drugs and Diagnostics.
M. Phillips (2010)
10.1111/bcp.12260
Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment.
K. Venkatakrishnan (2014)
10.1021/ja211888a
Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery
R. Tong (2012)
10.1016/j.ejmech.2018.03.007
Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?
S. de Castro (2018)
10.1016/j.ejps.2008.04.002
Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.
T. Dutta (2008)
10.1016/J.PHYSE.2004.07.013
Quantum dots in biology and medicine
R. E. Bailey (2004)
10.2967/jnumed.107.041723
Carbon Nanotubes: Potential Benefits and Risks of Nanotechnology in Nuclear Medicine
R. Reilly (2007)
Cellular mechanisms of multidrug resistance of tumor cells.
A. Stavrovskaya (2000)
10.1007/s00280-012-2042-4
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
J. Silverman (2012)
10.1007/s11095-006-9101-7
Intracellular Delivery of Saquinavir in Biodegradable Polymeric Nanoparticles for HIV/AIDS
Lipa K Shah (2006)
10.1016/j.jconrel.2015.01.010
Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms.
M. B. de Jesus (2015)
10.7150/thno.21194
A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions
J. Zhou (2018)
10.1248/bpb.b18-00223
Exosome Research and Co-culture Study.
T. Shimasaki (2018)
10.2147/IJN.S138624
Quantum dots in imaging, drug delivery and sensor applications
C. Matea (2017)
10.1097/APO.0000000000000059
Nanotechnology-Based Approaches for Ophthalmology Applications: Therapeutic and Diagnostic Strategies
Mehdi Ghaffari Sharaf (2014)
10.1080/10717544.2016.1276232
Basic concepts and recent advances in nanogels as carriers for medical applications
I. Neamţu (2017)
10.1016/j.msec.2017.06.004
Polymeric nanoparticles: A study on the preparation variables and characterization methods.
Carina Crucho (2017)
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol
P Chelle (2020)
10.3949/ccjm.78gr.11005
Updates in the medical management of Parkinson disease
H. Fernandez (2012)
10.1016/j.nano.2009.04.008
Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.
B. Mishra (2010)
10.1016/j.jconrel.2014.09.009
Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
Shixian Lv (2014)
10.1155/2017/9090325
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer
S. Jahan (2017)
10.2217/fca-2017-0009
Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial.
A. Kharlamov (2017)
10.1155/2015/415289
Bone Regeneration from PLGA Micro-Nanoparticles
I. Ortega-Oller (2015)
10.1086/514341
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
O. Cornely (2007)
10.3109/21691401.2014.953633
Application of liposomes in medicine and drug delivery
H. Daraee (2016)
10.2147/IJN.S84703
Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge
Gelareh Arzani (2015)
10.3109/10611869808995872
Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography.
R. Löbenberg (1998)
10.3109/03639045.2013.788012
Bacteriolysis by vancomycin-conjugated acryl nanoparticles and morphological component analysis
N. Shimizu (2014)
10.1002/jgm.1189
Gene transfer into guinea pig cochlea using adeno‐associated virus vectors
M. Konishi (2008)
10.1007/s00018-009-0053-z
Nanocarriers’ entry into the cell: relevance to drug delivery
H. Hillaireau (2009)
10.1021/ACS.BIOCONJCHEM.6B00437
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Y. Nakamura (2016)
10.1080/10611860600965914
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro
T. Dutta (2007)
10.1016/j.jconrel.2015.07.030
Using exosomes, naturally-equipped nanocarriers, for drug delivery.
E. Batrakova (2015)
10.1002/adma.201701460
Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications.
Hye-min Kim (2018)
10.3109/03602532.2013.859688
The effects of engineered nanoparticles on pulmonary immune homeostasis
R. Mohamud (2014)
10.2174/1568026614666140329232757
Liposomes as nanovaccine delivery systems.
K. A. Ghaffar (2014)
10.1016/j.jconrel.2014.05.025
Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
Ela Markovsky (2014)
10.1016/j.colsurfb.2012.06.021
Enhanced apatite-forming ability and cytocompatibility of porous and nanostructured TiO2/CaSiO3 coating on titanium.
H. Hu (2013)
10.1016/j.jconrel.2015.12.024
pH-responsive polymer-drug conjugates: Design and progress.
X. Pang (2016)
10.1186/s12951-018-0392-8
Nano based drug delivery systems: recent developments and future prospects
J. Patra (2018)
DENDRIMER APPLICATIONS – A REVIEW
H.N.Patel and Dr. P.M.Patel (2013)
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
T. Walsh (1999)
The intersection of nanotechnology, drug development, and personalized medicine
D Ho (2015)
10.1016/J.BMCL.2007.03.077
Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA.
E. Turos (2007)
10.3109/03639045.2015.1066798
Mucoadhesive nano-sized supramolecular assemblies for improved pre-corneal drug residence time
A. Fabiano (2015)
10.1097/APO.0000000000000171
Nanotechnology Applications for Glaucoma
Sibel Çetinel (2016)
10.2147/IJN.S37840
Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability
A. Neves (2013)
10.1016/j.drudis.2010.08.006
Cancer nanotechnology: application of nanotechnology in cancer therapy.
R. Misra (2010)
10.1038/s41565-019-0591-y
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc (2019)
10.1016/j.aanat.2011.04.007
Maxillary sinus floor augmentation using a nano-crystalline hydroxyapatite silica gel: case series and 3-month preliminary histological results.
L. Canullo (2012)
10.1039/c5bm00277j
Utilising inorganic nanocarriers for gene delivery.
X. J. Loh (2016)
10.1166/JNN.2013.6085
UV-enhanced cytotoxicity of CdTe quantum dots in PANC-1 cells depend on their size distribution and surface modification.
Shuquan Chang (2013)
10.1016/j.colsurfb.2014.03.044
Bactericidal effect of polyethyleneimine capped ZnO nanoparticles on multiple antibiotic resistant bacteria harboring genes of high-pathogenicity island.
S. Chakraborti (2014)
10.1517/13543780903114168
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
T. Boulikas (2009)
10.1016/j.actbio.2016.11.035
Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Qianhua Feng (2017)
10.1039/c8nr02358a
An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy.
Yuxia Pei (2018)
10.2217/nnm.10.107
Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.
Joshua Buse (2010)
10.1002/wnan.1409
Dendrimer-based nanocarriers: a versatile platform for drug delivery.
Hao-jui Hsu (2017)
10.7150/thno.10804
Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells
Hongxin Shen (2015)
10.2217/nnm.10.90
Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice.
Ashwin Bhirde (2010)
10.1016/j.jconrel.2017.08.033
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases
C. Tapeinos (2017)
10.1002/jbm.b.34046
Synthesis, characterization, and biological properties of composites of hydroxyapatite and hexagonal boron nitride.
Semra Unal (2018)
EquivaBone Osteoinductive Bone Graft Substitute
S. Warabi
10.1016/j.jcyt.2017.11.002
MSC-exosome: A novel cell-free therapy for cutaneous regeneration.
P. Wu (2018)
10.1016/S0167-7799(97)01036-6
Biomedical applications of nanotechnology--implications for drug targeting and gene therapy.
S. Davis (1997)
10.1093/brain/awr075
The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI.
Penny A. MacDonald (2011)
10.1023/A:1021267512805
The Use of Liposomes for Constructing Cell Models
T. Oberholzer (2002)
10.2174/157488410793352003
Nanotechnology for delivery of drugs and biomedical applications.
S. Leucuţa (2010)
10.1016/j.ejpb.2010.07.007
Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Shrinidh A Joshi (2010)
10.15171/apb.2015.022
Solid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent Breakthroughs.
Jafar Ezzati Nazhad Dolatabadi (2015)
10.3109/21691401.2014.930745
Nanogel—an advanced drug delivery tool: Current and future
A. Sharma (2016)
10.2165/00003495-200969060-00007
Ferric Carboxymaltose
K. Lyseng-Williamson (2012)
10.1023/A:1008159332152
Dexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells
Shintaro Warabi (2004)
10.1016/j.ijpharm.2007.11.035
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
M. Alipour (2008)
10.1016/j.jconrel.2012.03.020
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
10.1016/S1359-6349(10)70478-X
457 Preliminary results of a phase II study of lipoplatin (liposomal cisplatin)–vinorelbine combination as first line treatment in HER2/neu negative metastatic breast cancer (MBC)
F. Farhat (2010)
10.1002/cncr.22035
Emerging implications of nanotechnology on cancer diagnostics and therapeutics
A. Cuenca (2006)
10.1016/j.ejpb.2013.08.013
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
S. Weber (2014)
10.2147/IJN.S53079
Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic
S. Hussein-Al-Ali (2014)
10.1038/nrm2820
Sensors and regulators of intracellular pH
J. Casey (2010)
10.1039/C6TB03052A
Weak Bond-Based Injectable and Stimuli Responsive Hydrogels for Biomedical Applications.
Xiaochu Ding (2017)
10.1016/j.ijpharm.2010.10.038
Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Caixia Fan (2011)
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
A. Gabizon (1994)
10.1126/sciadv.1500439
Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine
D. Ho (2015)
10.1167/TVST.4.3.12
Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma.
M. M. Ibrahim (2015)
10.1016/j.jconrel.2016.05.044
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.
C. Saraiva (2016)
10.1016/j.preteyeres.2010.08.002
Applications of nanoparticles in ophthalmology
Y. Diebold (2010)
10.3390/jfb7020019
Stimuli-Responsive Gold Nanoparticles for Cancer Diagnosis and Therapy.
L. Tian (2016)
10.3390/ijms19071979
Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer
Priyanka Singh (2018)
10.1016/j.ejpb.2015.01.026
Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
G. Abrego (2015)
10.4161/mabs.27022
Site-specific antibody drug conjugates for cancer therapy
S. Panowski (2014)
10.1016/j.actbio.2016.04.024
Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Qianhua Feng (2016)
10.1248/bpb.b18-00133
Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
T. Yamashita (2018)
10.2147/IJN.S73185
Selective inhibition of liver cancer growth realized by the intrinsic toxicity of a quantum dot–lipid complex
D. Shao (2014)
10.1016/j.ijpharm.2012.07.033
In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus.
Subhankari Prasad Chakraborty (2012)
10.1177/0897190017725984
Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis
C. Bell (2018)
10.3390/ijms20236056
Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification
Jacob W Shreffler (2019)
10.1016/j.jcis.2018.02.053
Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.
Fang Chen (2018)
10.1016/j.apsb.2016.09.001
Nanotechnology-based strategies for treatment of ocular disease
Yuhua Weng (2017)
10.1016/j.jconrel.2010.07.097
Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.
F. R. Formiga (2010)
10.1038/nrd2614
Nanoparticle therapeutics: an emerging treatment modality for cancer
M. Davis (2008)
10.1517/17425247.2013.797405
Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications
S. Chandrasekhar (2013)
10.1002/jbm.b.32794
Synthesis and application of nanostructured calcium phosphate ceramics for bone regeneration.
D. Alves Cardoso (2012)
10.1016/j.addr.2016.08.014
Investigation of endosome and lysosome biology by ultra pH‐sensitive nanoprobes☆
Chensu Wang (2017)
10.1016/j.nano.2018.09.004
Protein-based nanoparticles in cancer vaccine development.
M. Neek (2019)
10.1080/10717540802321776
Polymeric nanoparticles for enhancing antiretroviral drug therapy.
T. Govender (2008)
Structural Biology of the TNFalpha Antagonists Used in the Treatment of Rheumatoid Arthritis
H Lim (2018)
10.1016/j.chemphyslip.2013.10.011
Novel methods for liposome preparation.
Yogita P Patil (2014)
10.1208/s12249-015-0290-4
Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use
Rathapon Asasutjarit (2015)
10.3390/ijms140917501
Materials Characterization of Feraheme/Ferumoxytol and Preliminary Evaluation of Its Potential for Magnetic Fluid Hyperthermia
J. Bullivant (2013)
10.1023/A:1011050209986
Targeting of 3′-Azido 3′-Deoxythymidine (AZT)-Loaded Poly(Isohexylcyanoacrylate) Nanospheres to the Gastrointestinal Mucosa and Associated Lymphoid Tissues
Assia Dembri (2004)
10.1007/s40005-017-0370-4
Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics
Y. Choi (2017)
10.2174/1567201813666161230142123
Role of Nanoparticles in Drug Delivery and Regenerative Therapy for Bone Diseases.
Sonia Gera (2017)
10.1073/PNAS.0504926102
Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain.
D. Bharali (2005)
10.1016/j.ejps.2012.12.007
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Shadab Md (2013)
10.1016/S0960-894X(00)00159-1
Antimycobacterial activity of ionic fullerene derivatives.
S. Bosi (2000)
10.1016/j.ejmech.2019.111682
Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985).
Zhuyu Xu (2019)
10.1128/AEM.06513-11
Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus
A. N. Brown (2012)
10.7150/thno.8074
Combining Microbubbles and Ultrasound for Drug Delivery to Brain Tumors: Current Progress and Overview
H. Liu (2014)
10.1016/j.ijpharm.2013.11.023
PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Maha Nasr (2014)
10.3727/096368909X12483162196881
Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine Neurons
D. Yurek (2009)
10.1007/s13311-011-0069-6
Cell Therapeutics in Parkinson’s Disease
O. Lindvall (2011)
10.3109/1061186X.2015.1020809
Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review
A. Kulkarni (2015)
10.1002/jgm.1152
Intravenous glial‐derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter
C. Xia (2008)
10.1124/dmd.112.044925
Nano-Advantage in Enhanced Drug Delivery with Biodegradable Nanoparticles: Contribution of Reduced Clearance
R. Kadam (2012)
10.1016/j.cis.2013.10.014
Advances in nanomedicines for malaria treatment.
N. P. Aditya (2013)
10.1038/354056a0
Helical microtubules of graphitic carbon
S. Iijima (1991)
10.1021/ACSAMI.6B08343
Regulation of Cell Signaling Factors Using PLGA Nanoparticles Coated/Loaded with Genes and Proteins for Osteogenesis of Human Mesenchymal Stem Cells.
J. Park (2016)
10.1021/JA0359310
Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other gram-positive bacteria at ultralow concentration.
Hongwei Gu (2003)
10.1093/mmy/myv036
Combination of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves antifungal effect against planktonic cells and biofilm of drug-resistant Candida albicans.
Carline Longhi (2016)
10.2147/IJN.S7653
Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis
K. Yudoh (2009)
10.1007/s11481-018-9785-6
HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication
Jonathan Herskovitz (2018)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar